Literature DB >> 15096211

Single phosphorylation of Tyr304 in the cytoplasmic tail of ephrin B2 confers high-affinity and bifunctional binding to both the SH2 domain of Grb4 and the PDZ domain of the PDZ-RGS3 protein.

Zhengding Su1, Ping Xu, Feng Ni.   

Abstract

The B class cell-attached ephrins mediate contact-dependent cell-cell communications and transduce the contact signals to the host cells through the binding interactions of their cytoplasmic domains. Two classes of intracellular effectors of B ephrins have been identified: one contains the PSD-95/Dlg/ZO-1 (PDZ) domain (for example PDZ-RGS3), and the second the Src homology 2 (SH2) domain (e.g. the Grb4 adaptor protein). The interaction with Grb4 requires phosphorylation of tyrosine residues on the conserved cytoplasmic C-terminal region of B ephrins, while binding to the PDZ domain is independent of tyrosine phosphorylation. However, the exact phosphorylation site(s) required for signaling remained obscure and it is also unknown whether the two classes of effectors can bind to B ephrins simultaneously or if the binding of one affects the binding of the other. We report here that phosphorylation of Tyr304 in the functional C-terminal region (residues 301-333) of ephrin B2 confers high-affinity binding to the SH2 domain of the Grb4 protein. Tyrosine phosphorylation at other candidate sites resulted in only minor change of the binding of Tyr304-phosphorylated ephrin B peptide (i.e. ephrinB2(301-333)-pY304) with the SH2 domain. (1)H-(15)N NMR HSQC experiments show that only the ephrinB2(301-333)-pY304 peptide forms a stable and specific binding complex with the SH2 domain of Grb4. The SH2 and PDZ domains were found to bind to the Tyr304 phosphopeptide both independently and at the same time, forming a three-component molecular complex. Taken together, our studies identify a novel SH2 domain binding motif, PHpY304EKV, on the cytoplasmic domains of B ephrins that may be essential for reverse signaling via the Grb4 adaptor protein alone or in concert with proteins containing PDZ domains.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15096211     DOI: 10.1111/j.1432-1033.2004.04078.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

Review 1.  Henipavirus receptor usage and tropism.

Authors:  Olivier Pernet; Yao E Wang; Benhur Lee
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

2.  Rhabdovirus-based vaccine platforms against henipaviruses.

Authors:  Drishya Kurup; Christoph Wirblich; Heinz Feldmann; Andrea Marzi; Matthias J Schnell
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

3.  Ephrin-B1 regulates axon guidance by reverse signaling through a PDZ-dependent mechanism.

Authors:  Jeffrey O Bush; Philippe Soriano
Journal:  Genes Dev       Date:  2009-06-10       Impact factor: 11.361

4.  ephrinB1 signals from the cell surface to the nucleus by recruitment of STAT3.

Authors:  Yong-Sik Bong; Hyun-Shik Lee; Laura Carim-Todd; Kathleen Mood; Tagvor G Nishanian; Lino Tessarollo; Ira O Daar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-22       Impact factor: 11.205

Review 5.  R4 RGS proteins: regulation of G-protein signaling and beyond.

Authors:  Geetanjali Bansal; Kirk M Druey; Zhihui Xie
Journal:  Pharmacol Ther       Date:  2007-10-05       Impact factor: 12.310

6.  Proteomic Analysis of NCK1/2 Adaptors Uncovers Paralog-specific Interactions That Reveal a New Role for NCK2 in Cell Abscission During Cytokinesis.

Authors:  Kévin Jacquet; Sara L Banerjee; François J M Chartier; Sabine Elowe; Nicolas Bisson
Journal:  Mol Cell Proteomics       Date:  2018-07-12       Impact factor: 5.911

7.  Presenilin-dependent intramembrane cleavage of ephrin-B1.

Authors:  Taisuke Tomita; Sayaka Tanaka; Yuichi Morohashi; Takeshi Iwatsubo
Journal:  Mol Neurodegener       Date:  2006-06-12       Impact factor: 14.195

8.  Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding.

Authors:  Magdalena L Bochenek; Sarah Dickinson; Jonathan W Astin; Ralf H Adams; Catherine D Nobes
Journal:  J Cell Sci       Date:  2010-03-16       Impact factor: 5.285

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.